(Q73288849)

English

Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as ‘in vivo purge’ and consolidative immunotherapy following autologous stem cell transplantation

scientific article published on 01 May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as 'in vivo purge' and consolidative immunotherapy following autologous stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as ‘in vivo purge’ and consolidative immunotherapy following autologous stem cell transplantation (English)

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

J. Mangel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

R. Buckstein

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

K. Imrie

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

D. Spaner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

E. Franssen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

P. Pavlin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

A. Boudreau

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

N. Pennell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

D. Combs

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

N. L. Berinstein

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12702531

25 December 2023

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

full work available at URL

https://academic.oup.com/annonc/article-pdf/14/5/758/567856/mdg201.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702531

25 December 2023

https://api.elsevier.com/content/article/PII:S092375341963509X?httpAccept=text/xml

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

https://api.elsevier.com/content/article/PII:S092375341963509X?httpAccept=text/plain

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

http://academic.oup.com/annonc/article-pdf/14/5/758/567856/mdg201.pdf

Portable Document Format

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

758-765

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

4

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

5

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

7

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

11

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

13

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

18

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

21

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment

22

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group

23

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma

24

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab

25

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

26

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study.

27

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Multiple roles for the major histocompatibility complex class I- related receptor FcRn

28

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

29

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Rituximab dose-escalation trial in chronic lymphocytic leukemia

30

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity

31

1 reference

10.1093/ANNONC/MDG201

https://api.crossref.org/works/10.1093/ANNONC/MDG201

25 December 2023

Identifiers

10.1093/ANNONC/MDG201

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12702531%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73288849&oldid=2144561135"